Market revenue in 2023 | USD 59.0 million |
Market revenue in 2030 | USD 84.7 million |
Growth rate | 5.3% (CAGR from 2023 to 2030) |
Largest segment | Frozen nondonor |
Fastest growing segment | Fresh Donor |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor |
Key market players worldwide | Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro fertilization market will help companies and investors design strategic landscapes.
Frozen nondonor was the largest segment with a revenue share of 48.31% in 2023. Horizon Databook has segmented the Mexico in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2018 to 2030.
Fertility tourism is one of the major factors contributing to the rising market share of the country. This can be attributed to the support offered to single parents as well as lesbian, gay, bisexual, and transgender individuals opting for ART without the requirement of a separate visa for the same.
Names of intended parents are listed on the birth certificate, and gender selection is allowed. A variety of IVF procedures like Intracytoplasmic sperm injection (ICSI), natural cycle IVF, mini-IVF, tandem IVF cycle, intrauterine insemination (IUI).
In Vitro Maturation (IVM), Intracytoplasmic morphologically selected sperm injection (IMSI), assisted hatching, and endometrial coculture are available in Mexico. Natural cycle IVF uses ICSI without any stimulating drugs.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico in vitro fertilization market , including forecasts for subscribers. This country databook contains high-level insights into Mexico in vitro fertilization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account